Daniel Hoffman
Papers
1
Total Citations
2
H-Index
1
About
Daniel Hoffman is a urologic researcher whose work centers on the management of lower urinary tract dysfunction, with a specific focus on optimizing treatments for non-neurogenic voiding dysfunction. His primary research area involves the use of intradetrusor botulinum toxin injections—a key therapy for overactive bladder and urinary retention—and he has made significant contributions by identifying predictors of adverse outcomes. In his most cited work, "PD39-11 Predictors of Urinary Retention in Male Patients Receiving Intradetrusor Botulinum Toxin Injections" (2017), Hoffman and his colleagues, including Ekene Enemchukwu, analyzed clinical factors that increase the risk of post-injection urinary retention in male patients. This study, cited 2 times, provides critical guidance for clinicians in patient selection and risk stratification, helping to reduce complications and improve treatment efficacy. Hoffman’s research bridges the gap between procedural innovation and patient safety, offering practical insights that enhance clinical decision-making in urology. His work is particularly valuable for trainees and practitioners seeking to refine their use of botulinum toxin therapy, as it underscores the importance of personalized medicine in managing complex voiding disorders.
Research Focus
Key Achievements
Top Papers
- 1